Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 98, Issue 2, 2012, Pages 257-263

  Tsai, Chia Jen ^a   Hsieh, Ching Jung ^a   Tung, Shih Chen ^a   Kuo, Ming Chun ^a   Shen, Feng Chih ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Adiponectin; Blood glucose fluctuations; Glutathione; Mean amplitude of glycemic excursions

Indexed keywords

ADIPONECTIN; CYSTEINE; GLUCOSE; GLUTATHIONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD GLUCOSE VARIABILITY; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED;

EID: 84870571889     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.09.013     Document Type: Article

References (31)

1. Abbas M.A. Robbins and Cotran pathologic basis of disease 2004, pp. 1191-2. 7th ed.
2. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687.
3. Ceriello A., Esposito K., Piconi L., Ihnat M.A., Thorpe J.E., Testa R., et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 57:1349-1354.
4. Wadén J., Forsblom C., Thorn L.M., Gordin D., Saraheimo M., Groop P.H., et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes 2009, 58(November):2649-2655.
5. Prince C.T., Becker D.J., Costacou T., Miller R.G., Orchard T.J. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 2007, 50:2280-2288.
6. Huang I.C., Wang P.W., Liu R.T., Tung S.C., Chen J.F., Kuo M.C., et al. The influence of self-monitoring blood glucose frequency on the oscillation of hemoglobulin A1c and chronic complications. Chang Gung Med J 2012, 35:46-53.
7. Szaleczky E., Prechl J., Fehér J., Somogyi A. Alterations in enzymatic antioxidant defence in diabetes mellitus - a rational approach. Postgrad Med J 1999, 75:13-17.
8. Saxena A.K., Srivastava P., Kale R.K., Baquer N.Z. Impaired antioxidant status in diabetic rat liver: effect of vanadate. Biochem Pharmacol 1993, 45:539-542.
9. Kaji H., Kurasaki M., Ito K., Saito T., Saito K., Niioka T., et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr 1985, 63:765-768.
10. Matkovics B., Varga S.I., Szabó L., Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 1982, 14:77-79.
11. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J Nutr 2004, 134:489-492.
12. Domínguez C., Ruiz E., Gussinye M., Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998, 21:1736-1742.
13. Darmaun D., Smith S.D., Sweeten S., Sager B.K., Welch S., Mauras N. Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 2005, 54:190-196.
14. Stamler J.S., Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev 1996, 54:1-30.
15. Wang J.S., Lin S.D., Lee W.J., Su S.L., Lee I.T., Tu S.T., et al. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week randomized, open-label, parallel-group comparison. Clin Ther 2011, 12:1932-1942.
16. Sun J., Xu Y., Deng H., Sun S., Dai Z., Sun Y. Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. J Mol Endocrinol 2010, 44:179-185.
17. Darmaun D., Welch S., Smith S., Sweeten S., Mauras N. Acute changes in blood glucose do not alter blood glutathione synthesis in adolescents with poorly controlled type 1 diabetes mellitus. Metabolism 2012, 61:373-378.
18. Toyo'oka T., Imai K. High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F). J Chromatogr 1983, 282:495-500.
19. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
20. Kilpatrick E.S., Rigby A.S., Atkin S.L. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 2008, 31:2198-2202.
21. Ceriello A. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes Nutr Metab 1999, 12:42-46.
22. Nobar R., Pour R. Total antioxidant capacity, superoxide dismutase and glutathione peroxidase in diabetic patients. Med J Islam Acad Sci 1999, 12:109-114.
23. Sailaja Y.R., Baskar R., Saralakumari D. The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radic Biol Med 2003, 35:133-139.
24. Yoshida K., Hirokawa J., Tagami S., Kawakami Y., Urata Y., Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995, 38:201-210.
25. Menon V., Ram M., Dorn J., Armstrong D. Oxidative stress and glucose levels in a population-based sample. Diabet Med 2004, 21:1346-1352.
26. van der Crabben S.N., Stegenga M.E., Blümer R.M., Muti P., Freudenheim J.L., Browne R., et al. Erythrocyte glutathione concentration and production during hyperinsulinemia, hyperglycemia, and endotoxemia in healthy humans. Metabolism 2011, 60:99-106.
27. Hoffstedt J., Arvidsson E., Sjölin E., Wåhlén K., Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 2004, 89:1391-1396.
28. Lin P., Chen L., Li D., Liu J., Yang N., Sun Y., et al. Adiponectin reduces glucotoxicity-induced apoptosis of INS-1 rat insulin-secreting cells on a microfluidic chip. Tohoku J Exp Med 2009, 217:59-65.
29. Ozeki N., Hara K., Yatsuka C., Nakano T., Matsumoto S., Suetsugu M., et al. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Metabolism 2009, 58:1470-1476.
30. Riestra P., García-Anguita A., Lasunción M.A., Cano B., de Oya M., Garcés C. Relationship of adiponectin with metabolic syndrome components in pubertal children. Atherosclerosis 2011, 216:467-470.
31. Morel F., Aninat C. The glutathione transferase kappa family. Drug Metab Rev 2011, 43:281-291.